What are you looking for? Search Common searches: Intranet, Contact, Map, Professionals, Teaching units, Research groups, Fulltext search Tipus de contingut Professionals Projects Teaching Units Collaborating entities News Activities - Any - Search News Anti-MOG antibodies are rare in patients with a first demyelinating flare suggestive of multiple sclerosis The ability to diagnose and differentiate both diseases as early as possible is fundamental to impact and stop the evolution of the disease before irreversible damage occurs. News Vall d'Hebron hosts a meeting on advances in the diagnosis, surveillance and prevention of pertussis The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year. News Vall d'Hebron promotes the national network ReALLNet to promote research in relapsed acute lymphoblastic leukaemia The initiative, coordinated by Dr. Pablo Velasco and Dr. Jose Luis Fuster, aims to bring innovation closer to patients and promote research projects in this disease. News RBDCOV project members meet at Vall d'Hebron to advance the development of the BIMERVAX vaccine RBDCOV aims to test the HIPRA vaccine against COVID-19 in children (including adolescents) and immunocompromised people. News Four Vall d'Hebron projects selected for the CaixaImpulse Health Innovation programme This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training. Professionals Meritxell Fernandez Fernandez Senior Project Manager, with more than 10 years of experience in CERCA centres, managing competitive projects. News The HITIHE project concludes with a meeting of all project members in Antwerp As part of the initiative, WikiTropica, a tool that provides health professionals with up-to-date information on infectious and tropical diseases, has been launched. News A single dose of attenuated vaccines could protect multiple sclerosis patients before starting immunosuppressive therapy This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment. News Vall d'Hebron discovers a new antibody in patients with scleroderma that will help in the diagnosis of this disease Researchers have used an innovative protocol to identify people with this autoimmune disease who have a higher risk of cancer. Professionals Ingrid Faura Sóc infermera gestora de la Unitat de Patologia Mamària de l'Hospital Universitari Vall d'Hebron. Pagination Previous page ‹‹ Page 156 Next page ››